‹ Screener

Profound Medical Corp.

PROF · Surgical & Medical Instruments & Apparatus · 36.3M shares · +17%/yr ↑ dilution · EDGAR filings ↗

Reference price $4.73 · est. market cap ~$172M — last insider purchase, 2025-05-16 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D46

Medical-device company (TULSA-PRO MRI-guided ablation devices) with operating losses and cash burn.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $2M2025-09-30 · $5M2025-12-31 · $6M2026-03-31 · $5M

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
70.8%
Operating margin
-256.3%
Net margin
-264.4%
Return on equity
-64.1%
Return on assets
-54.9%
ROIC
-45.9%
Revenue growth (QoQ)
-10.7%
Debt / equity
0.1×
Current ratio
12.5×
Free cash flow
-$38M
Tangible book value
$66M
Cash & investments
$60M
Cash runway
6q
Stock comp / revenue
34.1%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2025-05-16Menawat Arun SwarupBuy12K$4.73
2025-05-15Menawat Arun SwarupBuy10K$4.33

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-05-15Shareholder voteExhibitsfiling ↗
2026-05-14Reg FDExhibitsfiling ↗
2026-05-07ResultsExhibitsfiling ↗
2026-04-16Reg FDExhibitsfiling ↗
2026-04-14Reg FDExhibitsfiling ↗
2026-04-01Reg FDExhibitsfiling ↗
2026-03-27Reg FDExhibitsfiling ↗
2026-03-13Reg FDExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-05-152026-05-130001104659-26-062509 ↗
8-K2026-05-142026-05-140001171843-26-003441 ↗
10-Q2026-05-072026-03-310001104659-26-057198 ↗
8-K2026-05-072026-05-070001171843-26-003160 ↗
8-K2026-04-162026-04-160001171843-26-002497 ↗
8-K2026-04-142026-04-140001171843-26-002426 ↗
8-K2026-04-012026-04-010001171843-26-002146 ↗
8-K2026-03-272026-03-270001171843-26-001971 ↗
8-K2026-03-132026-03-130001171843-26-001553 ↗
8-K2026-03-102026-03-050001104659-26-025822 ↗
8-K2026-03-092026-03-090001171843-26-001406 ↗
10-K2026-03-052025-12-310001104659-26-024153 ↗